Quintiles To Open Central Laboratory in Mumbai, India
Expands Laboratory Network to Support Global, Regional Clinical Trials
Quintiles Transnational Corp. announced plans to open a central lab in Mumbai, India, further expanding the company's global network of labs that support global and regional clinical trials. The new lab, owned and operated by Quintiles, will be equipped and staffed before the end of 2006 and is expected to be ready to support new trials in the first quarter of 2007. The lab is located in Leela Business Park in Mumbai together with Quintiles' core clinical research and electrocardiogram (ECG) businesses.
Alan Ong, Vice President and General Manager, Quintiles Labs Asia, said: "Because we will be among the first global central laboratories in India, it also will help our sponsors expand their options to support global clinical trials, particularly regarding access to patients. For Quintiles, this allows us to further maximize our global reach while minimizing our customers' shipping costs, and because it is a fully owned facility, all operations from sample management to testing to final data transfer will be tightly controlled under our global core quality standard."
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Chiral Technologies Europe Acquires ChromTech Ltd. of U.K.
Aviation safety: Rapid test for harmful microbes in kerosene developed - Faster and more robust than a PCR test
Next generation solar fuels: How a record-breaking copper catalyst converts CO₂ into liquid fuels - Researchers have made real-time movies of copper nanoparticles as they evolve to convert carbon dioxide and water into renewable fuels and chemicals
Phenomenex: Zebron GC Columns Receive Two R&D 100 Awards
Rapid detection of antibiotic-resistant bacteria
Scientists create a DNA test that identifies Lyme disease in horses - A test under development by a Rutgers professor could have applications for humans and dogs, too
Neutrino detector starts measurement - New facility in France to measure fundamental properties of neutrinos
Analytik Jena Wins New Orders in China
New technology used to construct the first map of structural variation in the human genome - Methods also applicable to disease diagnosis, drug response tests